期刊文献+

CyclinD1和VEGF在非小细胞肺癌组织中的表达及其与预后的关系 被引量:17

Expression of Cyclin D1and Vascular Endothelial Growth Factor (VEGF )in Non-Small Cell Lung Carcinoma and Their Association with the Prognosis
下载PDF
导出
摘要 背景与目的:肿瘤的发生与发展由癌基因、抑癌基因及转移相关基因的特性所决定。细胞周期蛋白D1(CyclinD1)为癌基因CCND1的表达产物,血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)可调节肿瘤新生血管的形成,有助于肿瘤侵袭转移。本研究探讨非小细胞肺癌(non-smallcelllungcancer,NSCLC)病理组织中CyclinD1、VEGF的表达及与患者预后的关系。方法:采用免疫组织化学方法测定55例NSCLC和10例肺部非恶性病变病理切片中CyclinD1和VEGF的表达,并对55例NSCLC组织中CyclinD1和VEGF的表达与患者的年龄、性别、吸烟情况、瘤体大小、病理类型、组织分化程度、临床分期、淋巴结转移情况及生存时间进行统计分析。结果:55例肺癌病理组织中,CyclinD1和VEGF表达的阳性率分别是61.82%和74.55%;10例肺部非恶性病变标本中CyclinD1表达均为“-”,VEGF表达均为“-”。CyclinD1和VEGF表达:在不同年龄、性别,吸烟情况,瘤体大小,腺癌和鳞癌,不同组织分化程度,不同临床分期差异均无统计学意义;在有无淋巴结转移分组比较中差异均有统计学意义;表达阳性与阴性组生存分析差异均有统计学意义,提示CyclinD1与VEGF均有负性预后意义。结论:CyclinD1和VEGF在60%以上NSCLC中有表达,两者均可能影响NSCLC的生物学行为和预后。 BACKGROUND &OBJECTIVE:The occurrence and development of tumors are controled by oncog ene,antioncog ene and tumor metastasis-related g ene.Cyclin D1is the expressive product of CCND1(a kind of oncog en).Vascular endothelial g rowth facto r(VEGF )reg ulates the g rowth of neoplastic ang iog enesis ,which pla ys a role in the invasion and metastas is of tumor.The objecive of this study was to detect the expression of Cyclin D1and VEGF in non-small cell lung cancer (NSCLC),and to explore their association with the prog nosis of NSCLC.METHODS :Immunohistochemistry was used to detect the expression of Cyclin D1an d VEGF in patholog ical tissue sectio ns of 55cases of NSCLC and 10cases of non-m alig nant tissue from lung lesions.T he relationship between the expressio n of Cyclin D1and VEGF in 55NSCLC sections and the ag e,sex,smoke,siz e of tumor,histopatholog ical type,differentiation,stag e,lymph node metastasis and survival time were analyzed statistically.RESULTS :The expression rates of Cyclin D1and VEGF in the 55NSCLC tissue sections were 61.82%an d 74.55%,respectively.In 10cases o f non-malig nant tissue sections ,cyc lin D1expression was not detected an d VEGF expression(±)was only in 2cases.The expression of Cyclin D1and VEGF showed:(1)there was no sig nificant difference among ag e,sex,histopatholog ical type,stag e,dif ferenciation,tumor size and smokin g level;(2)there were sig nificant differences between the patients with and withou t lymph node metastasis ;(3)there were sig nificant differences of survival time between positive and neg ative expre ssion g roups.It meant Cyclin D1and V EGF would be the poor prog nostic factors.CONCLUSION:The expression of Cyclin D1and VEGF occurred in more than 60%c ases of NSCLC,which may play a role in the biolog ic behavior and pro g nosis of NSCLC.
出处 《癌症》 SCIE CAS CSCD 北大核心 2003年第1期86-90,共5页 Chinese Journal of Cancer
关键词 肿瘤转移 免疫组织化学 CcylinD1 VEGF 非小细胞肺癌 预后 Non-small cell lung carcinoma (NSCLC) Cyclin D1 Vascular endothelial g rowth factor (VEGF ) Immunohistochemistry
  • 相关文献

参考文献6

二级参考文献12

  • 1Rhim J S,Carcinogenesis,1998年,19卷,4期,673页
  • 2Chen Z,Cancer Res,1997年,57卷,10期,2013页
  • 3Mazure N,Cancer Res,1996年,56卷,3436页
  • 4Cannon-albright LA, Goldgar DE,Meyer LJ, et al. Assignment of a locus for familial melanoma, MLM, to chromosome9p13-p22[J].Science,1992;258(5085):1148~1152
  • 5Kamb A, Gruis NA, Weaver Feldhaus J, et al. A cell cycle zegulator petentiallyinvolved in genesis of many tumor types[J].Science,1994;264(5157):436~440
  • 6Li Y, Nichols MA,Shay JW, et al. Transcriptional repression of the D-typecyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene productpRb[J].Cancer Res,1994;54(23):6075~6082
  • 7Sakaguchi M,Fujii Y,Hirabayashi H,et al. Inversely correlated expression of p16 andRb protein in non-small cell lung cancers:an immunohistochemical study[J]. Int JCancer,1006;65(4):442~445
  • 8Serrano M,Hannon GJ, Beach D, et al.A new regulatory motif in cell-cycle controlcausing specific inhibition of cyclin D/CDK4[J].Nature,1993;366(6456):704~707
  • 9Mirsudomi T, Takahashi T. Genetic abnormalities in lung cancer and their prognosticimplication[J].Gan To Kagaku Ryoho,1996;23(8):990~996
  • 10Ariza A, Mate JL, Isamat M, et al.Standard and variant CD44 isoforma are commonlyexpressed in lung cancer of the non-small cell type but not of the small cell type[J]. JPathol,1995;177(4):363~368

共引文献59

同被引文献183

引证文献17

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部